Greece has officially launched an online platform taking applications for a drug that helps prevent COVID-19 in people who are at risk.
According to Greece’s Health Ministry, the monoclonal antibody medicine developed by AstraZeneca called Evusheld, that has been approved by the European Medicines Agency is now available at hospitals.
The medicine is approved for adults and adolescents from 12 years of age, weighing at least 40 kilograms, who have compromised immune systems and are also at risk of side-effects from the COVID vaccine.
They also need to be completely clear of the SARS-CoV-2 virus, without having been infected in at least three months.
The application for the two-injection dose of Evusheld needs to be submitted by the patient’s doctor, along with evidence supporting why they need the medicine instead of a vaccine.